Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-160518
Filing Date
2025-07-17
Accepted
2025-07-17 16:15:41
Documents
14
Period of Report
2025-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d17710d8ka.htm   iXBRL 8-K/A 30599
2 EX-10.2 d17710dex102.htm EX-10.2 39935
3 EX-10.3 d17710dex103.htm EX-10.3 39888
  Complete submission text file 0001193125-25-160518.txt   266650

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tsbx-20250626.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsbx-20250626_lab.xml EX-101.LAB 19445
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsbx-20250626_pre.xml EX-101.PRE 12152
17 EXTRACTED XBRL INSTANCE DOCUMENT d17710d8ka_htm.xml XML 5530
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41747 | Film No.: 251130815
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)